Cargando…

Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate

OBJECTIVES: U-Act-Early was a 2-year, randomized placebo controlled, double-blind trial, in which DMARD-naïve early RA patients were treated to the target of sustained remission (SR). Two strategies initiating tocilizumab (TCZ), with and without methotrexate (MTX), were more effective than a strateg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verhoeven, Maxime M A, Tekstra, Janneke, Welsing, Paco M J, Pethö-Schramm, Attila, Borm, Michelle E A, Bruyn, George A W, Bos, Reinhard, Griep, Ed N, Klaasen, Ruth, van Laar, Jacob M, Lafeber, Floris P J G, Bijlsma, Johannes W J, de Hair, Marjolein J H, Jacobs, Johannes W G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449801/ https://www.ncbi.nlm.nih.gov/pubmed/31859346 http://dx.doi.org/10.1093/rheumatology/kez602

Ejemplares similares

Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using Individual Patient Data From Multiple Clinical Trials
por: Verhoeven, Maxime M. A., et al.
Publicado: (2022)

Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy
por: Teitsma, Xavier M., et al.
Publicado: (2017)

Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab
por: Teitsma, Xavier M., et al.
Publicado: (2020)

Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores
por: Verhoeven, Maxime M. A., et al.
Publicado: (2022)

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
por: Teitsma, Xavier M, et al.
Publicado: (2018)

Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study
por: Verhoeven, Maxime M A, et al.
Publicado: (2021)

Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial
por: van der Leeuw, Matthijs S., et al.
Publicado: (2020)

Effectiveness of Remission Induction Strategies for Early Rheumatoid Arthritis: a Systematic Literature Review
por: Verhoeven, M. M. A., et al.
Publicado: (2019)

Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients
por: van der Leeuw, Matthijs S., et al.
Publicado: (2023)

Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach
por: Nair, Sandhya C., et al.
Publicado: (2016)

Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials
por: Teitsma, Xavier M., et al.
Publicado: (2016)

Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial
por: Messelink, Marianne A., et al.
Publicado: (2022)

Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density
por: Klop, Corinne, et al.
Publicado: (2016)

The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial
por: Jurgens, M. S., et al.
Publicado: (2020)

Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of prediction-aided decisions
por: van der Leeuw, Matthijs S., et al.
Publicado: (2022)

The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial
por: Bakker, Marije F, et al.
Publicado: (2011)

Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis
por: Cuppen, Bart V. J., et al.
Publicado: (2016)

Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis
por: Besselink, N. J., et al.
Publicado: (2019)

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study
por: Bakker, Marije F, et al.
Publicado: (2012)

The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies
por: Roodenrijs, Nadia M. T., et al.
Publicado: (2018)

What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis
por: Messelink, Marianne A, et al.
Publicado: (2023)

TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)
por: Kleinrensink, Nienke J, et al.
Publicado: (2022)

Tissue structure modification in knee osteoarthritis by use of joint distraction: an open 1-year pilot study
por: Intema, Femke, et al.
Publicado: (2011)

Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis
por: Gosselt, Helen R., et al.
Publicado: (2021)

Differences between serum polar lipid profiles of male and female rheumatoid arthritis patients in response to glucocorticoid treatment
por: Fu, Junzeng, et al.
Publicado: (2016)

Machine-learning predicted and actual 2-year structural progression in the IMI-APPROACH cohort
por: Jansen, Mylène P., et al.
Publicado: (2023)

A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients
por: Nair, S. C., et al.
Publicado: (2016)

The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm
por: Klop, Corinne, et al.
Publicado: (2015)

Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review
por: Vincken, Nanette L A, et al.
Publicado: (2022)

Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio
por: Gosselt, Helen R., et al.
Publicado: (2020)

Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study
por: Mastbergen, Simon C, et al.
Publicado: (2006)

Multi-classifier prediction of knee osteoarthritis progression from incomplete imbalanced longitudinal data
por: Widera, Paweł, et al.
Publicado: (2020)

Differentiation of naive CD4(+ )T cells towards T helper 2 cells is not impaired in rheumatoid arthritis patients
por: van Roon, Joël AG, et al.
Publicado: (2003)

Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with Psoriasis Only? A Systematic Review and Meta-Analysis
por: Pouw, Juliëtte N., et al.
Publicado: (2022)

Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohort
por: van Helvoort, Eefje M, et al.
Publicado: (2022)

Identifying multivariate disease trajectories and potential phenotypes of early knee osteoarthritis in the CHECK cohort
por: Altamirano, Sara, et al.
Publicado: (2023)

GaitSmart motion analysis compared to commonly used function outcome measures in the IMI-APPROACH knee osteoarthritis cohort
por: van Helvoort, Eefje M., et al.
Publicado: (2022)

Baseline clinical characteristics of predicted structural and pain progressors in the IMI-APPROACH knee OA cohort
por: van Helvoort, Eefje Martine, et al.
Publicado: (2021)

Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers
por: van Helvoort, Eefje M, et al.
Publicado: (2020)

COVID-19 related thrombi in ascending and descending thoracic aorta with peripheral embolization: a case report
por: Buikema, Jan W, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iiu1m8dsrgk900s0lfqejqkkgu